ARCHIVES

Rising Costs at NCI Threaten To Overtake Slim Increases In Budget Appropriations

This article is from The Cancer Letter archive.

Vol. 40 No. 13 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Bernard Fisher Says Mistake Was Not Publishing Sooner

April 22, 1994

In Brief: Best Guess On NCI Director: Brown First Choice, Benacerraf Second; FDa On Saccharin

April 22, 1977

Individualized Cancer Vaccines Show 90% Survival at 6 Months

December 27, 2013

NCI Still Trying To Broaden Group B Drug Distribution

May 5, 1978

Information Branches Combined Under ICIC, Moved to Office Of NCI Deputy Director

November 23, 1997

Also FDA clarifies data requirements for phase I IND applications.

April 29, 2005